PSA-PH(PSA-PH)
PSA-PH
$20.50—Stale · unknown old
NYSE • Last print unknown ago
$20.50—Stale · unknown old
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
No analyst price targets available for PSA-PH
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $5.12B | $5.58B | $5.85B | $6.58B | $7.34B |
| Low | $4.95B | $5.10B | $5.49B | $6.17B | $6.89B |
| High | $5.23B | $5.88B | $6.07B | $6.82B | $7.61B |
| EBITDA Avg | $3.51B | $3.43B | $3.45B | $3.66B | $3.44B |
| Low | $3.33B | $3.25B | $3.27B | $3.45B | $3.25B |
| High | $3.62B | $3.54B | $3.57B | $3.79B | $3.56B |
| EBIT Avg | $2.50B | $2.52B | $2.62B | $2.88B | $2.69B |
| Low | $2.32B | $2.34B | $2.44B | $2.67B | $2.50B |
| High | $2.61B | $2.63B | $2.74B | $3.01B | $2.81B |
| Net Income Avg | $1.76B | $1.78B | $1.86B | $2.07B | $1.92B |
| Low | $1.62B | $1.64B | $1.72B | $1.90B | $1.76B |
| High | $1.85B | $1.87B | $1.96B | $2.17B | $2.01B |
| EPS Avg | $10.03 | $10.14 | $10.60 | $11.76 | $10.89 |
| Low | $9.23 | $9.33 | $9.75 | $10.82 | $10.02 |
| High | $10.52 | $10.63 | $11.12 | $12.34 | $11.42 |
| Analysts (Rev / EPS) | 7 / 1 | 9 / 1 | 3 / 1 | 4 / 1 | 4 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $1.32B | $1.36B | $1.37B | $1.42B | $1.43B | $1.44B | $1.61B | $1.63B |
| Low | $1.25B | $1.25B | $1.28B | $1.33B | $1.33B | $1.34B | $1.50B | $1.52B |
| High | $1.36B | $1.40B | $1.41B | $1.47B | $1.48B | $1.49B | $1.65B | $1.68B |
| EBITDA Avg | $906M | $903M | $899M | $909M | $908M | $900M | $953M | $990M |
| Low | $857M | $854M | $850M | $858M | $856M | $849M | $896M | $930M |
| High | $927M | $924M | $921M | $931M | $930M | $922M | $978M | $1.02B |
| EBIT Avg | $627M | $632M | $636M | $653M | $657M | $656M | $714M | $756M |
| Low | $578M | $583M | $586M | $601M | $606M | $604M | $657M | $695M |
| High | $648M | $653M | $657M | $675M | $680M | $678M | $739M | $782M |
| Net Income Avg | $430M | $434M | $437M | $451M | $455M | $453M | $499M | $532M |
| Low | $392M | $396M | $398M | $410M | $414M | $413M | $455M | $485M |
| High | $447M | $451M | $454M | $468M | $472M | $471M | $519M | $553M |
| EPS Avg | $2.44 | $2.46 | $2.48 | $2.55 | $2.58 | $2.57 | $2.83 | $3.01 |
| Low | $2.22 | $2.24 | $2.26 | $2.32 | $2.34 | $2.34 | $2.58 | $2.74 |
| High | $2.53 | $2.56 | $2.57 | $2.65 | $2.68 | $2.67 | $2.94 | $3.13 |
| Analysts (Rev / EPS) | 5 / 1 | 5 / 1 | 4 / 1 | 4 / 1 | 4 / 1 | 4 / 1 | 3 / 1 | 3 / 1 |